Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.23.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenues:    
License and other revenues $ 346
Expenses:    
Research and development 8,041 10,545
General and administrative 3,997 4,224
Impairment of licensed technology 1,355
Impairment of right-of-use lease assets 1,561
Impairment of construction-in-progress 3,252
Total expenses 12,038 20,937
Loss from operations (12,038) (20,591)
Interest income 364 7
Interest expense (101) (201)
Change in fair value of warrant liabilities 2,265 (1,253)
Other income (loss) 403 (6)
Net loss $ (9,107) $ (22,044)
Basic and diluted loss per common share $ (0.54) $ (3.80)
Weighted average number of common shares outstanding – basic and diluted 16,904,024 5,795,107
Other comprehensive income (loss):    
Change in unrealized gains (losses) related to available-for-sale debt securities $ 64 $ (3)
Comprehensive loss $ (9,043) $ (22,047)